1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Kidney Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korstanje, R; Reznichenko, A | 1 |
| Doi, K; Fujita, T; Ishii, S; Kihara, Y; Kita, Y; Nakao, A; Negishi, K; Noiri, E; Okamoto, K; Shimizu, T; Suzuki, Y; Toda, A; Yokomizo, T | 1 |
| Choi, EK; Choi, IW; Choi, JH; Han, SJ; Im, SY; Kim, KJ; Ko, HM; Park, SJ | 1 |
| Sills, RH | 1 |
| Braquet, P; Claude, JR; Dutertre-Catella, H; Martin, C; Massicot, F; Warnet, JM | 1 |
| Alsina, J; Bordalba, JR; Carrera, M; Griño, JM; Martinez-Castelao, A; Moliner, R; Seron, D; Torras, J; Valles, J | 1 |
| Claude, JR; Godfroid, JJ; Heymans, F; Lamouri, A; Martin, C; Massicot, F; Pham-Huy, C; Warnet, JM | 1 |
| Arai, Y; Asano, M; Honda, K; Inagaki, O; Kasai-Nakagawa, C; Takanashi, M; Takenaka, T; Takizawa, K; Tanaka, A; Uchida, W; Yatsu, T | 1 |
| Clark, WF; Holub, BJ; Parbtani, A; Philbrick, DJ | 1 |
| Andres, G; Baglioni, C; Bussolino, F; Camussi, G; Tetta, C; Turello, E | 1 |
| Felsen, D; Vaughan, ED | 1 |
| Schlondorff, D | 1 |
| Remuzzi, G | 1 |
| Braquet, P; Colliez, P; Egido, J; Hosford, D; Pirotzky, E; Plante, G | 1 |
| Braquet, P; Colliez, P; Guilmard, C; Pirotzky, E | 1 |
| Alberton, M; Camussi, G; Coda, R; Macchiorlatti, E; Mariano, F; Montrucchio, G; Mularoni, E; Roffinello, C; Tetta, C | 1 |
| Braquet, P | 1 |
| Braquet, P; Pirotzky, E | 1 |
| Braquet, P; Egido, J; Gonzalez, E; Hernando, L; Mampaso, F; Ortiz, A; Ramirez, F; Robles, A; Sanchez Crespo, M | 1 |
| Benveniste, J; Chignard, M | 1 |
10 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Kidney Diseases
| Article | Year |
|---|---|
The role of platelet-activating factor in mesangial pathophysiology.
Topics: Animals; Humans; Kidney Diseases; Mesangial Cells; Platelet Activating Factor | 2015 |
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations.
Topics: Anemia, Hemolytic; Blood Coagulation Factors; Blood Platelets; Child; Diagnosis, Differential; Endothelium; Epoprostenol; Factor VIII; Female; Fever; Fibrinolytic Agents; Hemolytic-Uremic Syndrome; Humans; Kidney Diseases; Male; Neurologic Manifestations; Platelet Activating Factor; Purpura; Purpura, Thrombotic Thrombocytopenic; Thromboxane A2 | 1984 |
Dietary lipid modification of renal disorders and ether phospholipid metabolism.
Topics: Animals; Cytokines; Dietary Fats, Unsaturated; Eicosanoids; Fatty Acids, Omega-3; Fish Oils; Humans; Kidney Diseases; Membrane Lipids; Phospholipid Ethers; Platelet Activating Factor | 1991 |
Involvement of cytokines and platelet-activating factor in renal pathology.
Topics: Acute Kidney Injury; Animals; Cytokines; Humans; Interleukin-1; Kidney Diseases; Kidney Glomerulus; Monokines; Platelet Activating Factor; Tumor Necrosis Factor-alpha | 1990 |
Interactions of platelet activating factor and prostaglandins in the glomerulus and in mesangial cells.
Topics: Animals; Enzyme Activation; Glomerular Mesangium; Humans; Kidney Diseases; Kidney Glomerulus; Phospholipases A; Platelet Activating Factor; Prostaglandins; Type C Phospholipases | 1989 |
Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
Topics: Animals; Cyclosporins; Doxorubicin; Eicosanoids; Glomerular Filtration Rate; Glomerulonephritis; Humans; Kidney Diseases; Nephrosis; Platelet Activating Factor; Puromycin; Rabbits; Rats | 1989 |
Involvement of platelet-activating factor in renal processes.
Topics: Animals; Cyclosporins; Graft Rejection; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Nephritis; Platelet Activating Factor | 1989 |
Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Topics: Anaphylaxis; Animals; Bronchial Spasm; Diterpenes; Ginkgolides; Graft Rejection; Hemodynamics; Humans; Immune System Diseases; In Vitro Techniques; Kidney Diseases; Lactones; Leukocytes; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Shock; Thrombosis | 1986 |
[The role of the platelet-activating factor (PAF-acether) in renal pathology].
Topics: Animals; Graft Rejection; Humans; Kidney Diseases; Platelet Activating Factor; Renal Dialysis | 1988 |
A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Humans; Hypersensitivity; Kidney Diseases; Platelet Activating Factor; Rabbits; Vascular Diseases | 1985 |
11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Kidney Diseases
| Article | Year |
|---|---|
Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.
Topics: Animals; Chemokine CCL2; Chemotaxis; Fibrosis; Folic Acid; Inflammation; Kidney Diseases; Leukocytes; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Impairment of p38 MAPK-mediated cytosolic phospholipase A2 activation in the kidneys is associated with pathogenicity of Candida albicans.
Topics: Animals; Candida albicans; Candidiasis; Enzyme Inhibitors; Female; Gene Expression Regulation; Kidney Diseases; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylation; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Virulence | 2007 |
Renal syndromes and nonsteroidal antiinflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents; Humans; Kidney Diseases; Middle Aged; Platelet Activating Factor | 1984 |
Protection against cyclosporin-induced nephrotoxicity: 1. Effect of a PAF antagonist, BN50726.
Topics: Animals; Azepines; Creatinine; Cyclosporine; Drug Interactions; Glutathione; Kidney Cortex; Kidney Diseases; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thienopyridines; Urea | 1994 |
Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model.
Topics: Animals; Creatinine; Disease Models, Animal; Diterpenes; Ginkgolides; Hypertonic Solutions; Infusions, Intravenous; Infusions, Parenteral; Kidney Diseases; Kidney Function Tests; Lactones; Male; Nephrectomy; Plant Extracts; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury; Sodium | 1993 |
Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK1 oxidative injury.
Topics: Acetylglucosaminidase; Adenosine Diphosphate; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cyclosporine; Glutathione; Glutathione Peroxidase; Kidney Diseases; LLC-PK1 Cells; Oxidative Stress; Piperazines; Platelet Activating Factor; Platelet Aggregation Inhibitors; Swine | 1997 |
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
Topics: Anesthesia; Angiotensin II; Animals; Benzazepines; Dogs; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hemodynamics; Infusions, Intravenous; Isoquinolines; Kidney; Kidney Diseases; Kidney Function Tests; Male; Platelet Activating Factor; Receptors, Dopamine D1; Renal Circulation; Tetrahydroisoquinolines; Vasodilator Agents | 1997 |
This month in investigative urology: platelet activating factor: a mediator of renal pathology?
Topics: Animals; Humans; Kidney; Kidney Diseases; Platelet Activating Factor | 1990 |
[Renal diseases and platelet activating factor].
Topics: Acute Kidney Injury; Anaphylaxis; Animals; Cyclosporins; Diterpenes; Ginkgolides; Glomerulonephritis; Graft Rejection; Kidney Diseases; Lactones; Plant Extracts; Platelet Activating Factor; Proteinuria; Rabbits; Rats | 1989 |
The role of platelet-activating factor in experimental immune complex pathology.
Topics: Animals; Antigen-Antibody Complex; Blood Vessels; Capillary Permeability; Chemical and Drug Induced Liver Injury; Complement C3; Female; Heart Diseases; Immune Complex Diseases; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Platelet Activating Factor; Rabbits | 1985 |
Role of platelet-activating factor in adriamycin-induced nephropathy in rats.
Topics: Animals; Doxorubicin; Kidney; Kidney Diseases; Male; Methylprednisolone; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1987 |